PHASE 3 STUDY OF ADXS11-001 ADMINISTERED FOLLOWING CHEMORADIATION AS ADJUVANT TREATMENT FOR HIGH RISK LOCALLY ADVANCED CERVICAL CANCER: AIM2CERV (Advaxis IMmunotherapy 2 prevent CERVical recurrence)

Project: Other project

StatusFinished
Effective start/end date9/8/179/7/19

Funding

  • Advaxis Inc